Signals
The Most Powerful Oncology Tool This Week Was a Check-In
New PRO-TECT findings show weekly electronic symptom monitoring improved symptom control and physical function during advanced cancer treatment, with especially strong benefits for underserved groups. The technology is simple. The equity lesson is not.
Colon Cancer Immunotherapy Moves Into the Adjuvant Access Test
Optic Neuritis Moves Into the Neuroprotection Race
Personalised cardiology cannot succeed if women’s hearts still follow men’s pathways
Cancer Is Chaos. Patients Should Not Have to Become Their Own Operating System
Alzheimer’s Research Moves Beyond Amyloid
Pregnancy Vaccines Become a Trust Test as Medical Societies Step In
Precision cardiology is becoming the new oncology. Policy and reimbursement must catch up
CAR-T Starts Moving From Factory Medicine to In-Patient Engineering
Cellular Reprogramming Enters Neuro-Ophthalmology
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.